Extra Capital for Science Seed Fund supports UK Innovators labmate-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labmate-online.com Daily Mail and Mail on Sunday newspapers.
Jamie Murray s Top Picks: April 26, 2021
JPMorgan is preparing to offer a bitcoin fund to wealthy clients
Wall Street splits on dollarâs fate amid economic growth debate
Chinaâs biggest IPO this year looks to be in renewable power
What rotation? Some winning COVID stocks thrive amid reopening
Wall Streetâs trillion-dollar ESG club comes with huge tax perks
Darren Sissons Top Picks: April 23, 2021
A baseball card SPAC shows why distressed investing is so hard
Archegos thwarts Nomura s push to join Wall Street elite
Citi retail units seen fetching US$6B as sales kick off
Housing shock could upend Canadian asset values: Wolf
By Reuters Staff
2 Min Read
(Reuters) - Biotech startup Vaccitech, which owns the technology behind the COVID-19 vaccine developed by Oxford and AstraZeneca PLC, has confidentially filed for an initial public offering in the United States, the Financial Times reported on.ft.com/3rWvPuK on Wednesday.
The startup could price its offering as early as this month, the report said, citing people familiar with the matter.
The company did not immediately respond to a Reuters request for comment.
Vaccitech’s call to go with the U.S. market as the venue for its listing over the U.K. could further undermine London’s attempts to become a major financial hub, particularly after Brexit.
Future Planet Capital Buys VC Firm Midven
Posted on 04/08/2021
Future Planet Capital Holdings Limited (FPC) purchased Midven Ltd., a U.K. venture capital firm. The deal will enable Future Planet to grow its extensive global innovation network, which includes Berkeley, Cambridge, Harvard, MIT, and Oxford, by combining them with Midven’s access to U.K. Government funded scientific research.
Midven, which is supported by investors including the British Business Bank and European Investment Bank, manages the UK Innovation and Science Seed Fund (UKI2S) and the £35 million MEIF West Midlands Growth Fund, part of the British Business Bank’s £250 million Midlands Engine Investment Fund. Midven was originally established as a venture capital firm by six Midlands-based entrepreneurs over 30 years ago. The company then went through a management buy-out in 2007 when the current investment team acquired the business from the original founders.
Future Planet Capital acquires venture capital firm Midven
Future Planet Capital acquires venture capital firm Midven
Getty Images
Future Planet Capital has acquired U.K. venture capital firm Midven in a move that will enhance FPC s access to U.K. government-funded scientific research.
Spokesmen for both firms said terms of the deal were not disclosed.
Venture capital and impact investor FPC will grow its global innovation network, which includes the University of California, Berkeley, the University of Cambridge and Harvard University, through the deal. The firm invests in growth companies from the world s top universities, working with university spinoffs.
Midven, which has £110 million ($152 million) in assets under management, was acquired from management, the FPC spokeswoman said. The whole team will join from Midven, which will not be rebranded.